Cargando...
Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome
INTRODUCTION: Sjögren-Larsson syndrome (SLS) is a rare neurocutaneous disease characterized by ichthyosis, spasticity, intellectual disability and a distinctive retinopathy. It is caused by inactivating mutations in ALDH3A2, which codes for fatty aldehyde dehydrogenase (FALDH) and results in abnorma...
Guardado en:
| Publicado en: | Expert Opin Orphan Drugs |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4989507/ https://ncbi.nlm.nih.gov/pubmed/27547594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2016.1154453 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|